Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P J Elliott

Showing results (21-30 of 74) with videos related to

Pageof 8
Sort By:
General Pharmacology|March 1, 1992
Role of NK-2 receptors in the antidipsogenic activity of neurokinins in the mouseD M Walsh, P J Elliott, R M Hagan
Brain Research|October 22, 1986
Evidence for a tonic facilitatory influence of substance P on dopamine release in the nucleus accumbensP J Elliott, C B Nemeroff, C D Kilts
Australian and New Zealand Journal of Medicine|October 1, 1989
Zidovudine therapy in HIV-related thrombocytopeniaR A Kwiatek, E M Benson, P J Elliott
Journal of Immunological Methods|February 15, 1991
Two distinct monoclonal antibodies raised against mouse beta nerve growth factor. Generation of bi-specific anti-nerve growth factor anti-horseradish peroxidase antibodies for use in a homogeneous enzyme immunoassayR L Kenigsberg, P J Elliott, A C Cuello
Neuroscience Letters|August 3, 1992
Dopamine D1 and D2 receptor interactions in the MPTP-treated marmosetP J Elliott, D M Walsh, S P Close
European Journal of Pharmacology|March 17, 1992
Neurokinin agonists differentially affect A9 and A10 dopamine cells in the ratP Overton, P J Elliott, R M Hagan, et al.
Journal of Immunological Methods|September 29, 1989
Immunocytochemical use of internally radiolabelled monoclonal antibodies against tyrosine hydroxylase, substance P and enkephalinP J Elliott, A Ribeiro-da-Silva, R L Kenigsberg
Pharmacology, Biochemistry, and Behavior|October 1, 1990
Neuronal sites mediating locomotor hyperactivity following central neurokinin agonist administrationP J Elliott, J M Paris, H Mitsushio, et al.
Brain Research|September 3, 1986
Behavioral effects of neurotensin in the open field: structure-activity studiesP J Elliott, J Chan, Y M Parker, et al.
Immunopharmacology|June 1, 1996
Dissociation of blood-brain barrier permeability and the hypotensive effects of the bradykinin B2 agonist, RMP-7P J Elliott, N J Hayward, R L Dean, et al.
Pageof 8

Showing results (21-30 of 74) with videos related to

Sort By:
Pageof 8
General Pharmacology|March 1, 1992
Role of NK-2 receptors in the antidipsogenic activity of neurokinins in the mouseD M Walsh, P J Elliott, R M Hagan
Brain Research|October 22, 1986
Evidence for a tonic facilitatory influence of substance P on dopamine release in the nucleus accumbensP J Elliott, C B Nemeroff, C D Kilts
Australian and New Zealand Journal of Medicine|October 1, 1989
Zidovudine therapy in HIV-related thrombocytopeniaR A Kwiatek, E M Benson, P J Elliott
Journal of Immunological Methods|February 15, 1991
Two distinct monoclonal antibodies raised against mouse beta nerve growth factor. Generation of bi-specific anti-nerve growth factor anti-horseradish peroxidase antibodies for use in a homogeneous enzyme immunoassayR L Kenigsberg, P J Elliott, A C Cuello
Neuroscience Letters|August 3, 1992
Dopamine D1 and D2 receptor interactions in the MPTP-treated marmosetP J Elliott, D M Walsh, S P Close
European Journal of Pharmacology|March 17, 1992
Neurokinin agonists differentially affect A9 and A10 dopamine cells in the ratP Overton, P J Elliott, R M Hagan, et al.
Journal of Immunological Methods|September 29, 1989
Immunocytochemical use of internally radiolabelled monoclonal antibodies against tyrosine hydroxylase, substance P and enkephalinP J Elliott, A Ribeiro-da-Silva, R L Kenigsberg
Pharmacology, Biochemistry, and Behavior|October 1, 1990
Neuronal sites mediating locomotor hyperactivity following central neurokinin agonist administrationP J Elliott, J M Paris, H Mitsushio, et al.
Brain Research|September 3, 1986
Behavioral effects of neurotensin in the open field: structure-activity studiesP J Elliott, J Chan, Y M Parker, et al.
Immunopharmacology|June 1, 1996
Dissociation of blood-brain barrier permeability and the hypotensive effects of the bradykinin B2 agonist, RMP-7P J Elliott, N J Hayward, R L Dean, et al.
Pageof 8